What’s your mission?
Do you want to bring your invention to the patient? Let's join forces!
Combining an academic outlook with entrepreneurial activities can be a rocky road. At NLC, we share your goal: we want to bring your healthtech invention to the patient! NLC secures 100.000€ in startup funding right from the start and has collected valuable experience in overcoming obstacles by building startups at scale. We know the ins and outs of filing patents, securing start-up capital, and organising clinical trials. We know the best ways to bring your inventions to the market. You choose your degree of involvement. As a result, you can continue your academic work whilst developing your invention. Let us help you bring your invention to life!For Inventors
Do you want to make your mark in the World? Lead an innovative venture!
For each healthtech venture that we build, we recruit a start-up CEO to help pave the road ahead. They are responsible for fundraising, strategy and bringing the invention to the market. NLC's team of experienced experts and advisors is here to help every step of the way! We promise you are in good hands.For Entrepreneurs
Do you want to make a meaningful investment? Invest in healthtech ventures!
NLC offers professional and angel investors unique access to early-stage healthtech investment opportunities. Your investment could be the driving force behind a life-saving venture coming to the market! We ensure that the most promising, impactful, and life-changing technology reaches our investors through continuously gathering data and learnings in healthtech venture building.For Investors
Featured venturesSee all ventures
EARLY INTRAOPERATIVE ASSESSMENT OF AORTIC VALVE FUNCTIONALITYRead more
TRANSFORMING HEALTHCARE QUALITY MANAGEMENT BY REAL-TIME MONITORING
Let hospitals and supervisory bodies know there is a quality issue the moment it arises, using publicly available sourcesRead more
IMAGE ANALYSIS FOR THE IMPROVEMENT OF STROKE TREATMENT
Nico.Lab provides an algorithm to interpret medical scans of stroke victims, to make quick, calculated decisions on treatments and monitoringRead more
NewsSee all news
Eindhoven, the Netherlands, August 2, 2022 Haermonics, a clinical-stage breakthrough medtech company, has successfully closed a 4.3 M Series-A financing round with an investment…Read more
PRESS RELEASE July 15, 2022 AETHERUS, an NLC venture, sets out to improve the quality of life of patients suffering from Chronic Obstructive Pulmonary…Read more